ArticleJournal of hepatology2021

Identification of a novel long-acting 4'-modified nucleoside reverse transcriptase inhibitor against HBV.

Nobuyo Higashi-Kuwata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.